NCT01597011

Brief Summary

In hernia repair a mesh is used to close the defect in the abdominal wall. This mesh is either secured with tissue penetrating devices (ex. staples,tacks or sutures) or fibrin glue (Tisseel/Tissucol) or left unfixated. The investigators believe, and previous studies indicate, that the use of fibrin glue greatly reduces the amount of postoperative complications (ex. chronic pain, impaired ejaculation in men or recurrence of the hernia)when compared with the use of tacks or staples. The aim of this study is to compare the recurrence rates and amount of postoperative complications in patients who have had inguinal hernia repair with fibrin glue and in patients who have had inguinal hernia repair with tacks, staples or sutures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,340

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 11, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

March 18, 2015

Status Verified

March 1, 2015

Enrollment Period

2.2 years

First QC Date

May 9, 2012

Last Update Submit

March 17, 2015

Conditions

Keywords

Hernia, InguinalHernia repairFibrin Tissue AdhesiveTisseelTissucolRecurrenceChronic PainDysejaculation

Outcome Measures

Primary Outcomes (1)

  • Chronic pain

    Reported pain (questionnaire) from one year after procedure

    within period from one year after procedure until follow-up

Secondary Outcomes (2)

  • Recurrence

    within period from procedure to follow-up

  • dysejaculation

    Debut within period from procedure to follow-up

Study Arms (2)

Fibrin sealant group

Patients who have undergone laparoscopic inguinal hernia repair with fibrin sealant for mesh fixation

Procedure: Fibrin Sealant

Tissue-penetrating fixation group

Patients who have undergone laparoscopic inguinal hernia repair with the use of tacks, staples or sutures for mesh fixation

Procedure: Tissue-penetrating mesh-fixation

Interventions

Use of fibrin sealant for mesh fixation in laparoscopic inguinal hernia repair,

Also known as: Tisseel, Fibrin glue
Fibrin sealant group

Use of tacks, staples or sutures for mesh fixation in inguinal hernia repair

Also known as: Protacks, Hernia stapler
Tissue-penetrating fixation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be enrolled based on their registration in the Danish Hernia Database. All patients in the database who have undergone laparoscopic inguinal hernia repair from January 2009 to September 2012 will be included.

You may qualify if:

  • inguinal hernia repair from January 2009-September 2012

You may not qualify if:

  • Patients lost to follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev Hospital

Herlev, 2730, Denmark

Location

MeSH Terms

Conditions

Hernia, InguinalRecurrenceChronic Pain

Interventions

Fibrin Tissue Adhesive

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic ProcessesPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

FibrinBlood ProteinsProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • Neel M Helvind, Researcher

    Herlev Hospital

    PRINCIPAL INVESTIGATOR
  • Jacob Rosenberg, professor

    Herlev Hospital

    STUDY CHAIR
  • Andreas Q Fenger, Researcher

    Herlev Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
BSc.Med.

Study Record Dates

First Submitted

May 9, 2012

First Posted

May 11, 2012

Study Start

July 1, 2012

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

March 18, 2015

Record last verified: 2015-03

Locations